Position in GELS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,050
+$9,152 QoQ
Shares Held
15,000
+2204.1% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 6 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GELS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,498,556 across 77 Drug Manufacturers - Specialty & Generic names. GELS ranks #62 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in GELS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,050 | 15,000 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $898 | 651 | Shares | Defined | 2026-05-27 | |
| 2025-03-31 | $3,640 | 3,500 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||